Tempest Therapeutics, Inc.
TPSTNASDAQHealthcareBiotechnology
As of Oct 23, 2026 close
- Market cap
- $7.78M
- P/E (TTM)
- -
- Forward P/E
- -
- Dividend yield
- -
- 52-week range
- $0.57$11.13
- Volume (live)
- -
- Avg. volume (3M)
- 5.22M
Tempest Therapeutics (TPST) Stock Price & Financial Analysis
Tempest Therapeutics Stock Price Chart
Loading chart...
Financial Metrics & Key Statistics
Fundamental metrics, valuation ratios, and profitability indicators
| Day's Range | $0.50 - $0.54 |
|---|---|
| 52-Week High | $11.13 |
| 52-Week Low | $0.57 |
| Open | $0.53 |
| Volume (last close) | 52.22K |
| Average Volume (3M) | 5.22M |
| 50-Day MA | $0.91 |
|---|---|
| 200-Day MA | $1.60 |
| 1-Year Change | −94.94% |
| Market Cap | 7.78M |
|---|---|
| Shares Outstanding | 15.22M |
| Price to Book (P/B) | -7.14 |
| EV/EBITDA | -0.37 |
| Annual Dividend | $0.00 |
|---|---|
| Dividend Yield | 0.00% |
Source: Market prices and company fundamentals. Data as of Oct 23, 2026. Data sources and methodology
Tempest Therapeutics at a Glance
As of the Oct 23, 2026 close, Tempest Therapeutics (TPST) has a market capitalization of $7.78M.
As of its latest reported balance sheet, it holds $779.00K in cash and securities against $7.56M of debt, a net debt position of $6.78M.
Tempest Therapeutics does not currently pay a dividend.
The share price is down 94.9% over the past year. At $0.51 (the Oct 23, 2026 close) it sits near the bottom of its 52-week range of $0.57 to $11.13, below its 200-day moving average of $1.60.
Frequently Asked Questions About Tempest Therapeutics
What is the current stock price for TPST?
As of the Oct 23, 2026 close, TPST stock trades at $0.51. The 52-week range is $0.57–$11.13, with a day range of $0.50–$0.54.
What is the P/E ratio for TPST?
The P/E ratio (Price-to-Earnings) for TPST is shown in the Key Statistics section. This valuation metric helps compare Tempest Therapeutics, Inc. to industry peers.
Does TPST pay dividends?
Tempest Therapeutics does not currently pay a regular dividend. It reported a net loss over the trailing twelve months, so it has no earnings to distribute. Check the Dividends tab for historical dividend information.
What do analysts recommend for TPST?
Analyst ratings and recommendations for TPST are displayed in the Analyst Consensus section, including buy/hold/sell distribution and 12-month price targets.
What is the market cap of TPST?
As of the Oct 23, 2026 close, Tempest Therapeutics's market capitalization is $7.8M, classifying it as a micro-cap company. Tempest Therapeutics operates in the Healthcare sector within the Biotechnology industry.